237 results Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of three healthcare residences for the elderly at Leiden, Oss and Amersfoort. The three residences are operated by ECR/Blueprint Group. Stibbe advises on the equity offering of ProQR Stibbe advised the joint bookrunners Citigroup, Evercore ISI and RBC Capital Markets and the co-managers on the $104.1 million equity offering of ProQR Therapeutics N.V. ("ProQR"). Stibbe advises SleepScore Labs Stibbe advised SleepScore Labs on the acquisition of Sleep.ai, a Netherlands-based digital health company. Stibbe advises Lundbeck Stibbe advised Lundbeck on the acquisition of Prexton Therapeutics BV for an amount of up to EUR 905 million. Afdeling formuleert toetsingskader voor de heroverweging in bezwaar van ((niet)handhavings)besluiten De Afdeling bestuursrechtspraak van de Raad van State formuleert in haar uitspraak van 28 oktober 2020 het toetsingskader voor de heroverweging op bezwaar door een bestuursorgaan bij besluiten. FAQ: Hoe lang duurt een bestuursrechtelijke bezwaar- en (hoger) beroepsprocedure? Voor vrijwel alle betrokkenen bij een besluit speelt op enig moment de vraag hoe lang een bestuursrechtelijke bezwaar- dan wel (hoger) beroepsprocedure tegen dat besluit in beslag neemt. Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe. Muriël Rosing on panel for GIR Interactive Regional Spotlight The Global Investigations Review is organising the ‘GIR Interactive Regional Spotlight’. During the conference, Muriël Rosing will attend and speak at the panel “The view from continental Europe – key trends impacting compliance and investigations”. Marie-Julie Horseele Junior Associate Brussels Stibbe advises Aedifica Stibbe's Real Estate Transaction Group advised Aedifica NV, a Belgian listed company investing in healthcare real estate, on the further expansion of its portfolio in the Netherlands. Anya Murphy Junior Associate Brussels Stibbe advises pharmaceutical multinational Stibbe assisted a pharmaceutical multinational in complex litigations. Stibbe represents retail company Stibbe represented an upmarket department store company in the highly publicized proceedings before Belgium’s Supreme Court (Hof van Cassatie/Cour de cassation) regarding the validity of the national sales period legislation in light of EU law. Stibbe advises RWE DEA Representing RWE Dea (wax) in antitrust damage litigation in the District Court, following on from the European Commission’s finding of an antitrust infringement in the wax sector. Stibbe advises Martinair Holland Advising Martinair Holland with regard to the investigation by the European Commission into the air cargo sector. Stibbe advises several banks in the aftermath of the Lernaut & Hauspie debacle Stibbe represented Artesia Bank Nederland in the Lernout & Hauspie case before the Court of Appeal in Ghent regarding the possible confiscation of shares worth EUR 30 million. We also assisted Dexia Bank in the L&H case before Belgium's Supreme Court. Stibbe represents Belgian Ministry of Finance Stibbe represented the Ministry of Finance in annulment proceedings pursued by the Flemish Bar Council before the Constitutional Court against the Belgian Preventative Money Laundering Act. Stibbe advises KBC Securities Stibbe assisted KBC Securities as underwriters on the IPO of ThromboGenics on Euronext Brussels. Pagination Previous page Page 5 Current page 6 Page 7 Page 8 Next page
Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of three healthcare residences for the elderly at Leiden, Oss and Amersfoort. The three residences are operated by ECR/Blueprint Group.
Stibbe advises on the equity offering of ProQR Stibbe advised the joint bookrunners Citigroup, Evercore ISI and RBC Capital Markets and the co-managers on the $104.1 million equity offering of ProQR Therapeutics N.V. ("ProQR").
Stibbe advises SleepScore Labs Stibbe advised SleepScore Labs on the acquisition of Sleep.ai, a Netherlands-based digital health company.
Stibbe advises Lundbeck Stibbe advised Lundbeck on the acquisition of Prexton Therapeutics BV for an amount of up to EUR 905 million.
Afdeling formuleert toetsingskader voor de heroverweging in bezwaar van ((niet)handhavings)besluiten De Afdeling bestuursrechtspraak van de Raad van State formuleert in haar uitspraak van 28 oktober 2020 het toetsingskader voor de heroverweging op bezwaar door een bestuursorgaan bij besluiten.
FAQ: Hoe lang duurt een bestuursrechtelijke bezwaar- en (hoger) beroepsprocedure? Voor vrijwel alle betrokkenen bij een besluit speelt op enig moment de vraag hoe lang een bestuursrechtelijke bezwaar- dan wel (hoger) beroepsprocedure tegen dat besluit in beslag neemt.
Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe.
Muriël Rosing on panel for GIR Interactive Regional Spotlight The Global Investigations Review is organising the ‘GIR Interactive Regional Spotlight’. During the conference, Muriël Rosing will attend and speak at the panel “The view from continental Europe – key trends impacting compliance and investigations”.
Stibbe advises Aedifica Stibbe's Real Estate Transaction Group advised Aedifica NV, a Belgian listed company investing in healthcare real estate, on the further expansion of its portfolio in the Netherlands.
Stibbe advises pharmaceutical multinational Stibbe assisted a pharmaceutical multinational in complex litigations.
Stibbe represents retail company Stibbe represented an upmarket department store company in the highly publicized proceedings before Belgium’s Supreme Court (Hof van Cassatie/Cour de cassation) regarding the validity of the national sales period legislation in light of EU law.
Stibbe advises RWE DEA Representing RWE Dea (wax) in antitrust damage litigation in the District Court, following on from the European Commission’s finding of an antitrust infringement in the wax sector.
Stibbe advises Martinair Holland Advising Martinair Holland with regard to the investigation by the European Commission into the air cargo sector.
Stibbe advises several banks in the aftermath of the Lernaut & Hauspie debacle Stibbe represented Artesia Bank Nederland in the Lernout & Hauspie case before the Court of Appeal in Ghent regarding the possible confiscation of shares worth EUR 30 million. We also assisted Dexia Bank in the L&H case before Belgium's Supreme Court.
Stibbe represents Belgian Ministry of Finance Stibbe represented the Ministry of Finance in annulment proceedings pursued by the Flemish Bar Council before the Constitutional Court against the Belgian Preventative Money Laundering Act.
Stibbe advises KBC Securities Stibbe assisted KBC Securities as underwriters on the IPO of ThromboGenics on Euronext Brussels.